Raymond James Financial Inc. acquired a new stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 123,553 shares of the company’s stock, valued at approximately $3,177,000.
Other institutional investors have also modified their holdings of the company. Citigroup Inc. boosted its position in Perrigo by 94.1% during the third quarter. Citigroup Inc. now owns 151,520 shares of the company’s stock worth $3,974,000 after purchasing an additional 73,457 shares in the last quarter. Bank of Montreal Can lifted its stake in Perrigo by 347.0% in the 3rd quarter. Bank of Montreal Can now owns 145,474 shares of the company’s stock worth $3,731,000 after purchasing an additional 112,929 shares in the last quarter. FMR LLC boosted its stake in Perrigo by 66,795.3% during the third quarter. FMR LLC now owns 1,840,289 shares of the company’s stock worth $48,271,000 after buying an additional 1,837,538 shares during the last quarter. BNP Paribas Financial Markets raised its stake in Perrigo by 43.8% during the third quarter. BNP Paribas Financial Markets now owns 114,937 shares of the company’s stock worth $3,015,000 after purchasing an additional 35,031 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Perrigo in the third quarter valued at approximately $8,892,000. Hedge funds and other institutional investors own 95.91% of the company’s stock.
Insider Activity at Perrigo
In other news, EVP Ronald Craig Janish sold 7,800 shares of the stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.70% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Stock Report on Perrigo
Perrigo Trading Up 1.4 %
Shares of PRGO opened at $27.74 on Friday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The company has a market capitalization of $3.79 billion, a PE ratio of -23.71 and a beta of 0.48. The stock has a fifty day moving average of $26.03 and a two-hundred day moving average of $26.16. Perrigo Company plc has a fifty-two week low of $23.14 and a fifty-two week high of $33.46.
Perrigo (NYSE:PRGO – Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, topping analysts’ consensus estimates of $0.92 by $0.01. The firm had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.20 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. As a group, analysts forecast that Perrigo Company plc will post 2.56 EPS for the current year.
Perrigo Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 25th. Investors of record on Friday, March 7th were given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.18%. The ex-dividend date of this dividend was Friday, March 7th. This is an increase from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s dividend payout ratio is currently -92.80%.
Perrigo Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Read More
- Five stocks we like better than Perrigo
- How is Compound Interest Calculated?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What is the MACD Indicator and How to Use it in Your Trading
- Top 3 Beverage Stocks Pouring Out Profits
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.